Crucell Q4 net loss shrinks 81 pct on sales of Quinvaxem, travel ...

  • email Email to a friend
  • print Print version

Did you enjoy this article?

(total 0 votes)
Try our own cheap Booking Service242 times read : Adjust font size: Decrease font Enlarge font
image

Forbes - AMSTERDAM (Thomson Financial) - Crucell NV (nasdaq: CRXL - news - people ) said its net loss shrank by 81 pct to 4.8 mln eur in the fourth quarter from 24.9 mln eur a year earlier as sales were supported by the rollout of the Dutch biotech group's ...

Read this article...



Post your comment comment Comments (0 posted)

copyright